Coraopolis, PA, November 7, 2023 — Perigon Pharmacy 360 proudly announces its selection to participate in Ardelyx’s Limited Distribution Network for the revolutionary drug XPHOZAH®. XPHOZAH (tenapanor), is the first and only phosphate absorption inhibitor, and is indicated for treatment of adults with chronic kidney disease (CKD). This partnership marks a significant milestone for Perigon Pharmacy 360, establishing its commitment to …
Perigon Pharmacy 360 is excited to announce we have been selected to join Genentech’s Limited Distribution Network for HEMLIBRA. HEMLIBRA is a prescription medicine used for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children, ages newborn and older, with hemophilia A with or without factor VIII inhibitors. It’s the only subcutaneous injection for hemophilia A with or without inhibitors. …
Duchenne Muscular Dystrophy (DMD) is a severe genetic disorder characterized by rapid muscle degeneration, primarily affecting boys. Effective management of DMD necessitates strict adherence to complex medication regimens, which can be challenging. Perigon Pharmacy addresses these challenges through a comprehensive support system designed to enhance medication adherence and improve patient outcomes. Medication adherence is vital for DMD patients as it …
PITTSBURGH, June 6, 2024 /PRNewswire/ – Perigon Pharmacy 360, a leading provider of specialized pharmacy services for rare and complex conditions, proudly announces its exclusive partnership as the designated specialty pharmacy for the newly released generic deflazacort oral suspension, for the treatment of Duchenne muscular dystrophy (DMD). This partnership marks a significant stride in accessible healthcare solutions while reinforcing Perigon …
Coraopolis, PA, November 15, 2023 – Perigon Pharmacy 360 (Perigon), a leading precision digital pharmacy, proudly announces its selection to join Paratek Pharmaceuticals’ (Paratek) Limited Distribution Network for their breakthrough drug, NUZYRA®. This strategic partnership seamlessly aligns with Perigon’s mission to provide innovative healthcare solutions to patients in need. NUZYRA (omadacycline) is a novel antibiotic with both once-daily oral and …
— National direct-to-patient program allows patients and caregivers to obtain DYANAVEL XR extended-release tablet prescriptions from digital pharmacy — MONMOUTH JUNCTION, NJ, October 30, 2023 – Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity disorder (ADHD), pain, addiction and neurological disorders, today announced a new partnership with Perigon Pharmacy 360, a full-service, specialty digital pharmacy, to …
Considered one of the most anticipated events in the healthcare industry, Asembia’s Specialty Pharmacy Summit draws thousands of the nation’s leading pharmacy and pharmaceutical industry decision-makers to its annual conference. Each year, stakeholders from around the country gather to share new ideas, understand challenges, and define the future of healthcare with meaningful, innovative solutions for patients. And this year’s AXS23 …
We are commonly told in relationships that communication is key. And while we usually apply this logic to a loved-one, it should be used in many aspects of our lives, especially in healthcare. Effective communication with patients is the building block to successful treatment outcomes. Evidence shows that 40% to 80% of medical information that health care professionals communicate to …